Cleveland Clinic
PTEN Mutation Syndrome Leads to Breast Cancers With Distinct Molecular Alterations
A protein-coding sequence analysis uncovered somatic mutations that distinguished breast cancers in individuals with PTEN hamartoma tumor syndrome from sporadic breast cancers.
Anixa Biosciences, Cleveland Clinic Studying if Vaccine Prevents Triple-Negative Breast Cancer Relapse
The Phase I trial at the Cleveland Clinic will enroll up to 24 patients who received treatment for early-stage disease in the last three years, are cancer free, but at high relapse risk.
In Brief This Week: AstraZeneca, Daiichi Sankyo, Turning Point, Recursion, Cleveland Clinic
News items for the week of Oct. 4, 2021.
Personal Genome Diagnostics, Cleveland Clinic Join Forces to Advance Liquid Biopsy
Leaders from collaborating Cleveland Clinic institutes will work with PGDx to optimize its ctDNA test reporting and adapt its technology for new oncology applications.
The 20-year study showed the test provided an accurate assessment of the risk of long-term metastases and mortality for patients with localized prostate cancer.Â
Jun 22, 2020